This compound is a pharmaceutical intermediate specifically designed for the synthesis of quinolone antibiotics. It features a complex tricyclic structure with difluoro substitution, an ester functionality, and an ether bridge, making it a key building block in the manufacture of this antibiotic class.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 106939-34-8
Levofloxacin ethyl ester
pharmaceutical intermediate
Ofloxacin q acid
pharmaceutical intermediate
Levofloxacin q-acid
pharmaceutical intermediate
8,9-Difluoro-5-methyl-6,7-dihydro-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid
pharmaceutical intermediate
7-Chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
pharmaceutical intermediate
N,N,N-Trimethyl-1-(6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl)methanaminium iodide
pharmaceutical intermediate
6-Amino-3-(2-deoxy-beta-D-threo-pentofuranosyl)-1,3,5-triazine-2,4(1H,3H)-dione
pharmaceutical intermediate
1-Boc-amino-3,6,9-trioxaundecanyl-11-ol
pharmaceutical intermediate
ethyl (2S)-6,7-difluoro-2-methyl-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylate
TZSXJUSNOOBBOP-ZETCQYMHSA-N
CCOC(=O)C1=CN2[C@H](COC3=C2C(=CC(=C3F)F)C1=O)C